Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugatesRobert P. Lyon, Peter D. Senter, Tim D. Bovee et al.|Nature Biotechnology|2014Cited by 445
CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancersLeia M. Smith, P. J. Carter, Albina Nesterova et al.|British Journal of Cancer|2008Cited by 289